Previous work has suggested that standalone markers, such as p53, p21, Ki-67, PCNA, KRAS, and cyclin D1, cannot serve as efficient prognostic markers for NSCLC due to NSCLC heterogeneity [26–28]. The gene discussed is PCNA; the disease is non-small cell lung carcinoma.